BR0208463A - Compostos farmaceuticamente ativos - Google Patents

Compostos farmaceuticamente ativos

Info

Publication number
BR0208463A
BR0208463A BR0208463-5A BR0208463A BR0208463A BR 0208463 A BR0208463 A BR 0208463A BR 0208463 A BR0208463 A BR 0208463A BR 0208463 A BR0208463 A BR 0208463A
Authority
BR
Brazil
Prior art keywords
pharmaceutically active
active compounds
compounds
phosphodiesterases
monophosphate
Prior art date
Application number
BR0208463-5A
Other languages
English (en)
Inventor
Charlotte Moira Norfo Allerton
Kevin Neil Dack
Mark Ian Kemp
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR0208463A publication Critical patent/BR0208463A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"COMPOSTOS FARMACEUTICAMENTE ATIVOS". A presente invenção refere-se a compostos de fórmula geral (I): em que R^ 1^, R^ 2^, R^ 3^. R^ 4^, X, Y e A têm os significados dados aqui que são úteis no tratamento curativo e profilático de uma condição médica para a qual é desejada a inibição de 3^ '^,5^ '^-monofosfato cíclico de guanosina fosfodiesterases (por exemplo cGMp PDE5).
BR0208463-5A 2001-03-28 2002-03-19 Compostos farmaceuticamente ativos BR0208463A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0107751.0A GB0107751D0 (en) 2001-03-28 2001-03-28 Pharmaceutically active compounds
PCT/IB2002/000854 WO2002079203A1 (en) 2001-03-28 2002-03-19 Imidazo-triazine derivatives as pde 5 inhibitors

Publications (1)

Publication Number Publication Date
BR0208463A true BR0208463A (pt) 2004-03-02

Family

ID=9911744

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0208463-5A BR0208463A (pt) 2001-03-28 2002-03-19 Compostos farmaceuticamente ativos

Country Status (8)

Country Link
EP (1) EP1395589A1 (pt)
JP (1) JP2004528320A (pt)
AU (1) AU2002241211A1 (pt)
BR (1) BR0208463A (pt)
CA (1) CA2442329A1 (pt)
GB (1) GB0107751D0 (pt)
MX (1) MXPA03005990A (pt)
WO (1) WO2002079203A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002331064B2 (en) 2001-08-10 2007-08-23 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
DE10229778A1 (de) * 2002-07-03 2004-01-29 Bayer Ag Neue Verwendung von Imidazotriazinonen
JP2006219374A (ja) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Ｐｄｅ７阻害作用を有するイミダゾトリアジノン誘導体
TW200528455A (en) * 2003-12-19 2005-09-01 Bristol Myers Squibb Co Azabicyclic heterocycles as cannabinoid receptor modulators
DK1697371T3 (da) * 2003-12-19 2007-09-17 Bristol Myers Squibb Co Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
US7683060B2 (en) 2006-08-07 2010-03-23 Incyte Corporation Triazolotriazines as kinase inhibitors
LT3034075T (lt) 2006-11-22 2018-11-26 Incyte Holdings Corporation Imidazotriazinai ir imidazopirimidinai kaip kinazės inhibitoriai
NZ589622A (en) 2008-05-21 2012-10-26 Incyte Corp Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
AU2011269788B2 (en) 2010-02-03 2015-12-10 Incyte Holdings Corporation Imidazo[1,2-b][1,2,4]triazines as c-Met inhibitors
CN102372730B (zh) * 2010-08-19 2014-03-26 山东轩竹医药科技有限公司 桥环取代的磷酸二酯酶抑制剂
CN102382129B (zh) * 2010-08-19 2014-02-26 山东轩竹医药科技有限公司 螺环取代的磷酸二酯酶抑制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
PT1049695E (pt) * 1997-11-12 2002-07-31 Bayer Ag Imidazotriazinonas 2-fenil substituidas enquanto inibidores de fosfodiesterase
US6503908B1 (en) * 1999-10-11 2003-01-07 Pfizer Inc Pharmaceutically active compounds
DE10010067A1 (de) * 2000-03-02 2001-09-06 Bayer Ag Neue Imidazotriazinone und ihre Verwendung

Also Published As

Publication number Publication date
MXPA03005990A (es) 2005-02-14
JP2004528320A (ja) 2004-09-16
WO2002079203A8 (en) 2002-11-21
AU2002241211A1 (en) 2002-10-15
GB0107751D0 (en) 2001-05-16
EP1395589A1 (en) 2004-03-10
CA2442329A1 (en) 2002-10-10
WO2002079203A1 (en) 2002-10-10

Similar Documents

Publication Publication Date Title
BR0014695A (pt) 5-(2-substituìdo-5-heterociclilsulfonilpirid-3-il)-dihi dropirazolo[4,3-d]pirimidin-7-onas como inibidoras de fosfodiesterase
BR9905109A (pt) "compostos farmaceuticamente ativos"
GB0106661D0 (en) Pharmaceutically active compounds
BR9905877A (pt) Inibidores de pirazolopirimidinona de cgmp pde5 para o tratamento da disfunção sexual.
BR0004786A (pt) Compostos farmaceuticamente ativos
BR0004779A (pt) Compostos farmaceuticamente ativos
ATE250063T1 (de) Pyrazolopyrimidinone, cgmp pde5 inhibitoren, zur behandlung von sexuellen funktionsstörungen
BR0317891A (pt) Tratamento de ferimentos de pele usando polienilfosfatidil colina e alcanolaminas
ATE298238T1 (de) Pyrazolo(4,3-d)pyrimidinon-verbindungen als cgmp pde-inhibitoren
BR0115446A (pt) Processos para tratamento de condições associadas a quinase p38 e compostos pirrolotriazina úteis como inibidores de quinase
MXPA04005156A (es) Antagonistas del receptor de adenosina a2a.
BR0208463A (pt) Compostos farmaceuticamente ativos
DE50012571D1 (de) Biotin enthaltende galenische formulierung
BR0200843A (pt) Compostos farmaceuticamente ativos
AP2002002462A0 (en) Pharmaceutically active compounds.
BRPI0512013A (pt) composto, formulação farmacêutica, uso de um composto, método para profilaxia ou tratamento de uma arritmia, e, processo para preparação de um composto
WO2004037166A3 (en) Therapeutic guanidines
IT1307786B1 (it) Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali.
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
HUP0402241A2 (hu) Metformin és 4-oxo-butánsav kombinációját tartalmazó gyógyászati készítmény, és a készítmény alkalmazása diabétesz kezelésére
BRPI0415964A (pt) uso de um composto, composto, formulação farmacêutica, e, processo para preparar um composto
ECSP003706A (es) Compuestos farmaceuticamente activos
PE20030337A1 (es) Indan-1-onas sustituidas en c2 y sus derivados, procedimiento para su preparacion y su utilizacion como medicamentos
IL160603A0 (en) C2-disubstituted indan-1-ol systems and their derivatives, processes for their preparation and their use as pharmaceuticals

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 6A,7A E 8A ANUIDADES

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2055 DE 25/05/2010.